Post

CAS号: 1942114-09-1 英文名称: EAI-045 英文同义词: EA1045;EAI-045;CS-2350;EAI 045;EAI-045;EAI045;EAI 045;EAI-045;2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide;α-(5-fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-N-2-thiazolyl-2H-Isoindole-2-acetamide;N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide (EAI-045);2H-Isoindole-2-acetamide, α-(5-fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-N-2-thiazolyl-;2-(5-Fluoro-2-hydroxyphenyl)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-1,3-thiazol-2-ylacetamide 中文名称: EAI-045 中文同义词: 突变体EGFR变构抑制剂;2-(5-氟-2-羟基苯基)-2-(1-氧代异吲哚啉-2-基)-N-(噻唑-2-基)乙酰胺;ALPHA-(5-氟-2-羟基苯基)-1,3-二氢-1-氧代-N-2-噻唑基-2H-异吲哚-2-乙酰胺 分子式: C19H14FN3O3S 分子量: 383.4 Mol file 密度 : 1.546±0.06 g/cm3(Predicted) 酸度系数(pKa): 7.20±0.50(Predicted)